Gene · 2867
Papers2,791
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,791
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechanisms by which the intestinal microbiota affects gastrointestinal tumours and therapeutic effects. | Mol Biomed | 2023 | 38032415 | PubTator, text mining | PubMed |
| Research progress on the correlation between gut microbiota and preeclampsia: microbiome changes, mechanisms and treatments. | Front Cell Infect Microbiol | 2023 | 38029244 | PubTator, text mining | PubMed |
| Current and future research on the association between gut microbiota and breast cancer. | Front Microbiol | 2023 | 38029117 | PubTator, text mining | PubMed |
| Evaluation of cholesterol transformation abilities and probiotic properties of Bacteroides dorei YGMCC0564. | Front Microbiol | 2023 | 38029107 | PubTator, text mining | PubMed |
| Gut commensals and their metabolites in health and disease. | Front Microbiol | 2023 | 38029089 | PubTator, text mining | PubMed |
| The Characteristics, Mechanisms and Therapeutics: Exploring the Role of Gut Microbiota in Obesity. | Diabetes Metab Syndr Obes | 2023 | 38028999 | PubTator, text mining | PubMed |
| Intestinal homeostasis in the gut-lung-kidney axis: a prospective therapeutic target in immune-related chronic kidney diseases. | Front Immunol | 2023 | 38022571 | PubTator, text mining | PubMed |
| Genetic evidence supporting the causal role of gut microbiota in chronic kidney disease and chronic systemic inflammation in CKD: a bilateral two-sample Mendelian randomization study. | Front Immunol | 2023 | 38022507 | PubTator, text mining | PubMed |
| Structure-activity relationships andz interindividual variability of drug responses: pharmacogenomics with antimicrobial drugs as a paradigm. | J Int Med Res | 2023 | 38019107 | PubTator, text mining | PubMed |
| Variations in the Relative Abundance of Gut Bacteria Correlate with Lipid Profiles in Healthy Adults. | Microorganisms | 2023 | 38004667 | PubTator, text mining | PubMed |
| Prebiotics, Probiotics, and Synbiotics-A Research Hotspot for Pediatric Obesity. | Microorganisms | 2023 | 38004665 | PubTator, text mining | PubMed |
| Gut Microbiome-Based Therapeutics in Critically Ill Adult Patients-A Narrative Review. | Nutrients | 2023 | 38004128 | PubTator, text mining | PubMed |
| Effects of Dietary Components on Mast Cells: Possible Use as Nutraceuticals for Allergies? | Cells | 2023 | 37998337 | PubTator, text mining | PubMed |
| Characterization of gut microbiome composition in Iranian patients with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. | Sci Rep | 2023 | 37996480 | PubTator, text mining | PubMed |
| Trans-vaccenic acid reprograms CD8+ T cells and anti-tumour immunity. | Nature | 2023 | 37993715 | PubTator, text mining | PubMed |
| Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis. | Gut Microbes | 2023 | 37979154 | PubTator, text mining | PubMed |
| ACT001 Alleviates chronic kidney injury induced by a high-fat diet in mice through the GPR43/AMPK pathway. | Lipids Health Dis | 2023 | 37978497 | PubTator, text mining | PubMed |
| Melatonin, BAG-1 and cortisol circadian interactions in tumor pathogenesis and patterned immune responses. | Explor Target Antitumor Ther | 2023 | 37970210 | PubTator, text mining | PubMed |
| Alleviation of DSS-induced colitis via bovine colostrum-derived extracellular vesicles with microRNA let-7a-5p is mediated by regulating Akkermansia and β-hydroxybutyrate in gut environments. | Microbiol Spectr | 2023 | 37966243 | PubTator, text mining | PubMed |
| Regulation of Macronutrients in Insulin Resistance and Glucose Homeostasis during Type 2 Diabetes Mellitus. | Nutrients | 2023 | 37960324 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2867/papers?page=17